Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines
Top Cited Papers
- 1 July 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 51 (1) , 52-61
- https://doi.org/10.1016/j.jaad.2003.12.031
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Evidence for an Autoimmune Pathogenesis of VitiligoPigment Cell Research, 2003
- Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligoJournal of Dermatological Science, 1999
- Pathophysiology of vitiligoClinics in Dermatology, 1997
- Immune mechanisms in vitiligoClinics in Dermatology, 1997
- Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo.The Journal of Dermatology, 1997
- Alterations in IL-6, IL-8, GM-CSF. TNF-α, and IFN-γ Release by Peripheral Mononuclear Cells in Patients with Active VitiligoJournal of Investigative Dermatology, 1997
- RECENT INVESTIGATIONS ON VITILIGO VULGARISDermatologic Clinics, 1997
- Neuropeptide and neuronal marker studies in vitiligoBritish Journal of Dermatology, 1994
- Serum antibodies in vitiligo patientsClinics in Dermatology, 1989
- On the etiology of vitiligo and gray hairPublished by Elsevier ,1971